<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00960635</url>
  </required_header>
  <id_info>
    <org_study_id>336/00</org_study_id>
    <nct_id>NCT00960635</nct_id>
  </id_info>
  <brief_title>Immunointervention With Calcitriol in New-Onset Type 1 Diabetes</brief_title>
  <official_title>Immunointervention With 1,25-dihydroxy-vitamin D3 in New-onset Type 1 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut fur Diabetesforschung, Munich, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut fur Diabetesforschung, Munich, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, two-arm, placebo-controlled phase-2 trial to determine whether the
      daily intake of 1,25-dihydroxy-vitamin D3 [1,25(OH)2D3], improves beta cell function in
      patients with recently diagnosed type 1 diabetes. The treatment consists of the daily oral
      administration of 0.25 Âµg 1,25(OH)2D3 or placebo for 9 months and an equal follow-up time
      without supplementation. Fasting, peak and AUC C-peptide concentrations during a 2-hour mixed
      meal tolerance test are measured at the beginning of the study, as well as at the end of the
      treatment and the follow-up period in month 9 and 18. The null hypothesis is that there is no
      difference between 1,25(OH)2D3 treated subjects and the placebo group in the AUC C-peptide at
      month 18.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2001</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Prevention</primary_purpose>
  </study_design_info>
  <number_of_arms>2</number_of_arms>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>calcitriol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>pill without agent</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>1,25-dihydroxy-vitamin D3 (calcitriol)</intervention_name>
    <arm_group_label>calcitriol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>pill without agent</description>
    <arm_group_label>pill without agent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  New onset Typ 1 diabetes (&lt; 6 weeks insulin therapy)

          -  Age 18-39 years

          -  GADA and/or IA-2A positive

        Exclusion Criteria:

          -  Kidney disease

          -  Pregnancy

          -  Lactating
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Anette G Ziegler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut fuer Diabetesforschung</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut fuer Diabetesforschung</name>
      <address>
        <city>Munich</city>
        <zip>80804</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2009</study_first_submitted>
  <study_first_submitted_qc>August 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2009</study_first_posted>
  <last_update_submitted>August 17, 2009</last_update_submitted>
  <last_update_submitted_qc>August 17, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 18, 2009</last_update_posted>
  <responsible_party>
    <name_title>Anette Ziegler, MD</name_title>
    <organization>Institut fuer Diabetesforschung</organization>
  </responsible_party>
  <keyword>new-onset</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Calcitriol</mesh_term>
    <mesh_term>Dihydroxycholecalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

